Ernesto Galbán-Rodríguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ernesto Galbán-Rodríguez has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ricardo Arencibia-Jorge
Universidad Nacional Autónoma de México
4 shared publications - Deborah Torres Ponjuán
Faculty of Communication, University of Havana, Havana, Cuba
2 shared publications - Humberto Carrillo-Calvet
Complexity Sciences Center and Faculty of Sciences National Autonomous University of Mexico Mexico City Mexico
2 shared publications - Lourdes García-García
Instituto Nacional de Salud Publica (INSP), Cuernavaca, Mexico
2 shared publications Antonieta M Herrera
Vaccine Division, Center for Genetic Engineering and Biotechnology of Havana, P.O. Box 6162, Havana 10600, Cuba
1 shared publicationCarlos A Duarte
Vaccine Division, Center for Genetic Engineering and Biotechnology of Havana, P.O. Box 6162, Havana 10600, Cuba
1 shared publication
Latest Publications
- 6 March 2021
- Published by Springer Nature in Scientometrics
- Vol. 126 (3) , 2643-2665
Multidimensional quantitative analysis of the Cuban scientific output and its regional context
- 6 March 2021
- Published by Springer Nature in Scientometrics
- Vol. 126 (3) , 2643-2665
Multidimensional quantitative analysis of the Cuban scientific output and its regional context
- Open Access
The multidisciplinary nature of COVID-19 research
Objective We analyzed the scientific output after COVID-19 and contrasted it with studies published in the aftermath of seven epidemics/pandemics: Severe Acute Respiratory Syndrome (SARS), Influenza A virus H5N1 and Influenza A virus H1N1 human infections, Middle East Respiratory Syndrome (MERS), Ebola virus disease, Zika virus disease, and Dengue. Design/Methodology/Approach We examined bibliometric measures for COVID-19 and the rest of studied epidemics/pandemics. Data were extracted from Web of Science, using its journal classification scheme as a proxy to quantify the multidisciplinary coverage of scientific output. We proposed a novel Thematic Dispersion Index (TDI) for the analysis of pandemic early stages. Results/Discussion The literature on the seven epidemics/pandemics before COVID-19 has shown explosive growth of the scientific production and continuous impact during the first three years following each emergence or re-emergence of the specific infectious disease. A subsequent decline was observed with the progressive control of each health emergency. We observed an unprecedented growth in COVID-19 scientific production. TDI measured for COVID-19 (29,4) in just six months, was higher than TDI of the rest (7,5 to 21) during the first three years after epidemic initiation. Conclusions COVID-19 literature showed the broadest subject coverage, which is clearly a consecuence of its social, economic, and political impact. The proposed indicator (TDI), allowed the study of multidisciplinarity, differentiating the thematic complexity of COVID-19 from the previous seven epidemics/pandemics. Originality/Value The multidisciplinary nature and thematic complexity of COVID-19 research were successfully analyzed through a scientometric perspective.
Open AccessThe multidisciplinary nature of COVID-19 research
Objective We analyzed the scientific output after COVID-19 and contrasted it with studies published in the aftermath of seven epidemics/pandemics: Severe Acute Respiratory Syndrome (SARS), Influenza A virus H5N1 and Influenza A virus H1N1 human infections, Middle East Respiratory Syndrome (MERS), Ebola virus disease, Zika virus disease, and Dengue. Design/Methodology/Approach We examined bibliometric measures for COVID-19 and the rest of studied epidemics/pandemics. Data were extracted from Web of Science, using its journal classification scheme as a proxy to quantify the multidisciplinary coverage of scientific output. We proposed a novel Thematic Dispersion Index (TDI) for the analysis of pandemic early stages. Results/Discussion The literature on the seven epidemics/pandemics before COVID-19 has shown explosive growth of the scientific production and continuous impact during the first three years following each emergence or re-emergence of the specific infectious disease. A subsequent decline was observed with the progressive control of each health emergency. We observed an unprecedented growth in COVID-19 scientific production. TDI measured for COVID-19 (29,4) in just six months, was higher than TDI of the rest (7,5 to 21) during the first three years after epidemic initiation. Conclusions COVID-19 literature showed the broadest subject coverage, which is clearly a consecuence of its social, economic, and political impact. The proposed indicator (TDI), allowed the study of multidisciplinarity, differentiating the thematic complexity of COVID-19 from the previous seven epidemics/pandemics. Originality/Value The multidisciplinary nature and thematic complexity of COVID-19 research were successfully analyzed through a scientometric perspective.
- Open Access
- 21 June 2020
- Published by Pro-Metrics in Iberoamerican Journal of Science Measurement and Communication
- Vol. 1 (1) , 003
The multidisciplinary nature of COVID-19 research
Objective. We analyzed the scientific output after COVID-19 and contrasted it with studies published in the aftermath of seven epidemics/pandemics: Severe Acute Respiratory Syndrome (SARS), Influenza A virus H5N1 and Influenza A virus H1N1 human infections, Middle East Respiratory Syndrome (MERS), Ebola virus disease, Zika virus disease, and Dengue. Design/Methodology/Approach. We examined bibliometric measures for COVID-19 and the rest of the studied epidemics/pandemics. Data were extracted from Web of Science, using its journal classification scheme as a proxy to quantify the multidisciplinary coverage of scientific output. We proposed a novel Thematic Dispersion Index (TDI) for the analysis of pandemic early stages. Results/Discussion. The literature on the seven epidemics/pandemics before COVID-19 has shown explosive growth of the scientific production and continuous impact during the first three years following each emergence or re-emergence of the specific infectious disease. A subsequent decline was observed with the progressive control of each health emergency. We observed an unprecedented growth in COVID-19 scientific production. TDI measured for COVID-19 (29,4) in just six months, was higher than TDI of the rest (7,5 to 21) during the first three years after epidemic initiation. Conclusions. COVID-19 literature showed the broadest subject coverage, which is clearly a consequence of its social, economic, and political impact. The proposed indicator (TDI), allowed the study of multidisciplinarity, differentiating the thematic complexity of COVID-19 from the previous seven epidemics/pandemics. Originality/Value. The multidisciplinary nature and thematic complexity of COVID-19 research were successfully analyzed through a scientometric perspective.
- 21 June 2020
- Published by Pro-Metrics in Iberoamerican Journal of Science Measurement and Communication
- Vol. 1 (1) , 003
Open AccessThe multidisciplinary nature of COVID-19 research
Objective. We analyzed the scientific output after COVID-19 and contrasted it with studies published in the aftermath of seven epidemics/pandemics: Severe Acute Respiratory Syndrome (SARS), Influenza A virus H5N1 and Influenza A virus H1N1 human infections, Middle East Respiratory Syndrome (MERS), Ebola virus disease, Zika virus disease, and Dengue. Design/Methodology/Approach. We examined bibliometric measures for COVID-19 and the rest of the studied epidemics/pandemics. Data were extracted from Web of Science, using its journal classification scheme as a proxy to quantify the multidisciplinary coverage of scientific output. We proposed a novel Thematic Dispersion Index (TDI) for the analysis of pandemic early stages. Results/Discussion. The literature on the seven epidemics/pandemics before COVID-19 has shown explosive growth of the scientific production and continuous impact during the first three years following each emergence or re-emergence of the specific infectious disease. A subsequent decline was observed with the progressive control of each health emergency. We observed an unprecedented growth in COVID-19 scientific production. TDI measured for COVID-19 (29,4) in just six months, was higher than TDI of the rest (7,5 to 21) during the first three years after epidemic initiation. Conclusions. COVID-19 literature showed the broadest subject coverage, which is clearly a consequence of its social, economic, and political impact. The proposed indicator (TDI), allowed the study of multidisciplinarity, differentiating the thematic complexity of COVID-19 from the previous seven epidemics/pandemics. Originality/Value. The multidisciplinary nature and thematic complexity of COVID-19 research were successfully analyzed through a scientometric perspective.
- 12 October 2019
- Published by Springer Nature in Scientometrics
- Vol. 121 (2) , 1019-1043
Measuring the Cuban scientific output in scholarly journals through a comprehensive coverage approach
- 12 October 2019
- Published by Springer Nature in Scientometrics
- Vol. 121 (2) , 1019-1043
Measuring the Cuban scientific output in scholarly journals through a comprehensive coverage approach
- 3 June 2004
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 82 (8) , 500-509
Nonviral DNA vectors for immunization and therapy: design and methods for their obtention
The use of plasmid DNA for vaccination and therapy is a relatively novel technology, with advantages and limitations as with other gene transfer techniques. The technology is based on DNA vectors designed for administering genes coding for relevant proteins into a given organism, fulfilling requirements of the regulatory agencies that once properly formulated and delivered the desired vaccine/therapeutic effect can be achieved. Starting from conventional plasmid DNA vectors currently tested in clinical trials, improvement resulted in bacterial element-less vectors, increasing the complexity of the developmental process. The present review focuses on systems described for generating these nonviral DNA vectors for immunization and therapy from bacterial hosts (conventional and conditionally replicating plasmids, nonreplicating minicircles, and linear dumbbell-shaped expression cassettes) in vivo or in vitro. Additionally, nontherapeutic genetic sequences with a negative or positive effect according to the specific application are described, bringing a better comprehension of the technology’s state of the art.
- 3 June 2004
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 82 (8) , 500-509
Nonviral DNA vectors for immunization and therapy: design and methods for their obtention
The use of plasmid DNA for vaccination and therapy is a relatively novel technology, with advantages and limitations as with other gene transfer techniques. The technology is based on DNA vectors designed for administering genes coding for relevant proteins into a given organism, fulfilling requirements of the regulatory agencies that once properly formulated and delivered the desired vaccine/therapeutic effect can be achieved. Starting from conventional plasmid DNA vectors currently tested in clinical trials, improvement resulted in bacterial element-less vectors, increasing the complexity of the developmental process. The present review focuses on systems described for generating these nonviral DNA vectors for immunization and therapy from bacterial hosts (conventional and conditionally replicating plasmids, nonreplicating minicircles, and linear dumbbell-shaped expression cassettes) in vivo or in vitro. Additionally, nontherapeutic genetic sequences with a negative or positive effect according to the specific application are described, bringing a better comprehension of the technology’s state of the art.
- 5 September 2003
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 308 (4) , 713-718
Enhanced cell-mediated IFN-γ-secreting activity against the HIV-1IIIB V3 peptide of the TAB9 multiepitope after DNA vaccine backbone engineering
- 5 September 2003
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 308 (4) , 713-718
Enhanced cell-mediated IFN-γ-secreting activity against the HIV-1IIIB V3 peptide of the TAB9 multiepitope after DNA vaccine backbone engineering